Company Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.
The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy.
The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system.
The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020.
Zomedica Corp. is headquartered in Ann Arbor, Michigan.
| Country | United States |
| Founded | 2015 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 144 |
| CEO | Larry Heaton |
Contact Details
Address: 100 Phoenix Drive, Suite 190 Ann Arbor, Michigan 48108 United States | |
| Phone | 734 369 2555 |
| Website | zomedica.com |
Stock Details
| Ticker Symbol | ZOM |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001684144 |
| CUSIP Number | 98980M109 |
| ISIN Number | CA98980M1095 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Larry C. Heaton II | President, Chief Executive Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 19, 2024 | 8-K | Current Report |
| Nov 19, 2024 | 8-K | Current Report |
| Nov 8, 2024 | 8-K | Current Report |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Oct 16, 2024 | UPLOAD | Filing |
| Sep 16, 2024 | UPLOAD | Filing |
| Aug 14, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 10-Q | Quarterly Report |
| Jul 3, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |